Method for increasing the efficacy of cancer therapy by administering an anti-FOLR1 immunoconjugate
US11932701B2 · kind B2 · utility
0Cited by
37References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 10, 2021 |
| Grant date | Mar 19, 2024 |
| Priority date | — |
| Expiry date | Feb 1, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention generally relates to antibodies that bind to human folate receptor and diagnostic assays for folate receptor 1-based therapies. Methods of using the antibodies to monitor therapy are further provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.